news roundup
Global, not-for-profit The Pistoia Alliance, has lauched a new project to analyze how a digital, real-world data collection tool is used during a clinical trial, aiming to define standards for collecting patient-centric data in a way that provides value for a particular therapeutic area.
ERT acquired APDM Wearable Technologies, a provider of wearables and digital biomarkers, and will integrate Patient Reported Outcomes data captured by ERT’s eCOA platform with data from APDM’s wearables and digital endpoints.
BioAgilytix has announced that it is now offering customizable COVID-19 testing packages with services to address sponsor needs stemming from the coronavirus pandemic.
|
|
advertisement
Clinical Trials: Navigating Disruption to Thriving Wednesday, June 17, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Read the article Brand Insights - Thought Leadership | Almac
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
|
|
|
|
advertisement
IRT: A Competitive Advantage to Accelerate Clinical Trials Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing. But, how can modern systems give sponsors the edge to develop drugs as quickly as possible and at a lower cost, two factors that are particularly advantageous when developing drugs and vaccines amidst a global pandemic?
Read the article Brand Insights - Thought Leadership | Almac
|
|
Articles |
In this latest article by Ann Neuer, Applied Clinical Trials examines early response by sites, sponsors and CROs to ensure the trials that needed to keep running, did.
|
JoAnne Schaberick, Co-CEO of Pro-ficiency, discusses how her company’s simulation training platform is helping provide remote clinical trial site training, compliance, and communication tools to sponsors and study sites.
|
advertisement
Beyond EDC – Don’t Just Capture Data, Collect It Tuesday, June 23, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Read the article
|
|
Blog Posts
In this blog, Gen Li, President of Phesi suggests sponsors take time while clinical trials are on hold to analyze whether those trials are better left unstarted.
|
advertisement
Harnessing CAR-T Therapy for Hematologic Malignancies and Solid Tumors: Experience from City of Hope
Read the article
|
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|